Special Poster Feature: American Association for the Study of Liver Diseases (Aasld): The Liver Meeting® 2016 Coverage by Chris Ontiveros

“…The Liver Meeting®, the official meeting of the American Association for the Study of Liver Diseases (AASLD), held in Boston, Massachusetts, USA, supported the presentation of recent clinical and basic research in liver disease by renowned experts, to target the diverse needs of hepatology professionals. …”
Get full text

Radiological diagnosis of hepatocellular carcinoma does not preclude biopsy before treatment by Bleuenn Brusset, Marion Jacquemin, Yann Teyssier, Gaël S. Roth, Nathalie Sturm, Matthieu Roustit, Alexandre Bône, Julien Ghelfi, Charlotte E. Costentin, Thomas Decaens

Subjects: “…American Association for the study of Liver Diseases 2011…”
Get full text

Prevalence of chronic hepatitis B phases in Eritrean patients: a laboratory-based cross-sectional study by Mohammed Elfatih Hamida, Saud Mohammed Raja, Yemane Seyoum, Isam Mohammed Elkhidir, Freweini Tekle

Subjects: “…American Association for the Study of Liver Diseases guidelines…”
Get full text

The Liver Meeting 2014: Summary of Presentations on Genotype 3 HCV Infection from the 65th Annual Liver Meeting of the American Association for the Study of Liver Diseases (AASLD), Held in Boston, MA, USA, on 7th-11th November, 2014 by Markus Peck, Stanislas Pol

“…The 65th American Association for the Study of Liver Diseases Annual Meeting, The Liver Meeting® 2014, took place in Boston, Massachusetts, USA, on 7th–11th November 2014. …”
Get full text

Malignancy in primary sclerosing cholangitis: Bile duct, liver, and colon by Chapman, R

“…. © 2014 by the American Association for the Study of Liver Diseases.…”

CT/MRI Liver Imaging Reporting and Data System (LI-RADS): Standardization, Evidence, and Future Direction by Yeun-Yoon Kim, Jin-Young Choi

“…The CT/MRI LI-RADS version 2018 has been incorporated in the American Association for the Study of Liver Diseases guidance. This review examines the effect of CT/MRI LIRADS on the standardized reporting of liver imaging, and the evidence in diagnosing HCC and evaluating treatment response after locoregional treatment using CT/MRI LI-RADS. …”
Get full text

Hepatic encephalopathy syndrome: current aspects of diagnosis and treatment by D. I. Trukhan

“…This article examines current aspects of diagnosis and treatment of hepatic encephalopathy, taking into account the recommendations of the European Association for the Study of the Liver (EASL) and the American Association for the Study of Liver Diseases (AASLD).…”
Get full text

Radiologic Diagnosis of Hepatocellular Carcinoma by Woo Kyoung Jeong

“…It was recently included in the clinical guidance of the American Association for the Study of Liver Diseases. In addition, the radiologic findings of hepatocellular carcinoma (HCC) enable a prediction of the prognosis after treatment and a diagnosis of diseases because the use of gadoxetic acid MRI has become more common. …”
Get full text

Serum Immunoglobulin G4 and Immunoglobulin G1 for Distinguishing Immunoglobulin G4-Associated Cholangitis From Primary Sclerosing Cholangitis by Boonstra, K, Culver, E, Wenniger, L, van Heerde, M, van Erpecum, K, Poen, A, van Nieuwkerk, K, Spanier, B, Witteman, B, Tuynman, H, van Geloven, N, van Buuren, H, Chapman, R, Barnes, E, Beuers, U, Ponsioen, C

“…The current American Association for the Study of Liver Diseases practice guidelines for PSC advise on the measurement of specific Ig (sIg)G4 in PSC patients, but interpretation of elevated sIgG4 levels remains unclear. …”

Features of Treatment of Patients Infected with Hepatitis C Virus Genotypes 1 And 4 by Direct-Acting Antiviral Drugs by V.P. Shypulin, A.A. Kuzminets

“…Current guidelines of the European Association for the Study of the Liver (EASL), American Association for the Study of Liver Diseases (AASLD) and the Canadian Association for the Study of the Liver (CASL) on the treatment of patients with HCV genotypes 1 and 4 are also compared.…”
Get full text

Key Elements on the Pathway to HCV Elimination: Lessons Learned From the AASLD HCV Special Interest Group 2020 by Jordan J. Feld, John W. Ward

“…Accordingly, the 2020 HCV Special Interest Group symposium at the annual American Association for the Study of Liver Diseases Liver Meeting examined policies and strategies for the scale‐up of HCV testing and expanded access to HCV care and treatment outside the specialty setting, including primary care and drug treatment and settings for care of persons who inject drugs and other marginalized populations at risk for HCV infection. …”
Get full text

Tenofovir alafenamide in the treatment of chronic hepatitis B virus infection: rationale and clinical trial evidence by Ruth Byrne, Ivana Carey, Kosh Agarwal

“…In two randomized, double-blind, multinational phase III trials in patients with hepatitis B e antigen (HBeAg)-positive or -negative infection, TAF 25 mg was non-inferior to TDF 300 mg in achieving the primary efficacy outcome of a hepatitis B virus (HBV) DNA level < 29 IU/ml at week 48 and was associated with higher rates of alanine aminotransferase (ALT) normalization based on AASLD (American Association for the Study of Liver Diseases) criteria. TAF was well tolerated with low rates of adverse events, comparable to TDF. …”
Get full text

Management of Clinically Significant Itch in Cholestatic Liver Disease by Cynthia Levy, Gideon Hirschfield, Andreas Kremer, Kidist Yimam

“…At a satellite symposium presented at the 2022 meeting of the American Association for the Study of Liver Diseases (AASLD) in Washington, D.C., USA, leading experts discussed the importance of assessing itch in all patients with one of these cholestatic liver diseases. …”
Get full text

Step by Step: Managing the Complications of Cirrhosis by Perez IC, Bolte FJ, Bigelow W, Dickson Z, Shah NL

“…In this review, we discuss pathophysiology, clinical features and management of common complications of liver cirrhosis based on literature review and the current clinical practice guidelines of the American Association for the Study of Liver Diseases (AASLD).Keywords: cirrhosis, chronic liver disease, end-stage liver disease, decompensated cirrhosis, compensated cirrhosis, hepatorenal syndrome…”
Get full text

Transesophageal echocardiography in orthotopic liver transplantation: a comprehensive intraoperative monitoring tool by Luigi Vetrugno, Federico Barbariol, Umberto Baccarani, Francesco Forfori, Giovanni Volpicelli, Giorgio Della Rocca

“…The American Association for the Study of Liver Diseases states that transesophageal echocardiography should be used in all liver transplant candidates in order to assess chamber sizes, hypertrophy, systolic and diastolic function, valvular function, and left ventricle outflow tract obstruction. …”
Get full text

Esteatose e esteatohepatite não-alcoólica nos pacientes com hepatite crônica pelo vírus da hepatite C Steatosis and non-alcoholic steatohepatitis in patients with chronic hepatitis... by Gabriela Coral, Angelo Alves de Mattos, Ângelo Zambam de Mattos, Diogo Edele dos Santos

“…Staging of hepatitis C was scored by Brazilian Classification and the diagnosis of non-alcoholic steatohepatitis by the American Association for the Study of Liver Diseases criteria RESULTS: Steatosis was found in 65 of 120 cases (54.2%); it was mild in 37/65 (56.9%), moderate in 12/65 (18.5%) and severe in 10/65 (15.4%). …”
Get full text

Dynamical observation on biological progression of VX2 liver tumors to identify the optimal time for intervention in animal models. by Zhenguang Wang, Guangjie Yang, Pei Nie, Junhua Fu, Xufu Wang, Dan Liu

“…PURPOSE: Based on practice guideline of "management of hepatocellular carcinoma (HCC): update" published by American Association for the Study of Liver Diseases (AASLD) and "Barcelona Clinic Liver Cancer staging system (BCLC)," this study investigated how to enroll the optimal VX2 liver tumor model for HCC researches by dynamically observing the biological progression of the tumor. …”
Get full text

New perspectives in the pharmacological treatment of Hepatitis C by Sol Gomez Aparicio, Juan Vicente Esplugues, Fernando Alegre Guerra

“…<strong><br /> Materials and methods:</strong> Several systematic searches were made in the PubMed database; in the articles from the "liver meeting" congress of AASLD (American Association for the Study of Liver Diseases) in November 2014 and in the EASL (European Association for the Study of Liver) guide. …”
Get full text

Large volume paracentesis of 39.5 liters chylous ascites in the setting of high-grade follicular lymphoma by Joseph A. Hughes, III, MD, Thomas H. Bishop, MD, Eric D. Mcloney, MD, Sarah L. Thomas, MD, John M. Wessinger, MD

“…The American Association for the Study of Liver Diseases recognizes large volume paracentesis as draining greater than 5 liters of ascites and states there is no limit in the amount of ascites drained with appropriate replacement of albumin. …”
Get full text

Expert opinion on the management of hepatitis C infection in Kuwait by Saad MF, Alenezi S, Asker H

“…While international guidelines from the American Association for the Study of Liver Diseases (AASLD) and European Association for the Study of the Liver (EASL) do address this evolving treatment landscape, the cost-driven treatment prioritization of patients by these guidelines and unique HCV genotype presentation in the Kuwaiti population prompted the development of a more tailored approach. …”
Get full text